About

Breakthroughs in biotech and AI are reshaping industries, economies, and the balance of power between companies and countries. I spend my time understanding how — and helping others see what's coming.

I'm a biotech and AI analyst with a PhD in Physical Chemistry and over a decade of experience across scientific research, the pharmaceutical industry, and media. My analytical work on AI-driven drug discovery, pharma R&D transformation, and competitive dynamics in biotech has been cited by Deloitte, Forbes, RAND Corporation, the European Parliament, and the US Department of Energy, as well as in peer-reviewed research published by Springer Nature, Elsevier, and other scientific journals.

In 2016, I co-founded BiopharmaTrend.com, a biotech media and intelligence platform covering AI in drug discovery and the digital transformation of pharma. I built the editorial operation, led the analytical research, and grew it into a recognized industry resource with a company database, weekly deep dives, and a newsletter reaching over 12,000 subscribers.

Before media and analysis, I spent eight years at Enamine, a global supplier of fine chemicals and compound libraries for the pharmaceutical industry, where I served as Director of E-commerce and Marketing. Before that, I worked as a research scientist in bioinorganic and supramolecular chemistry, thin polymer films, nanomaterials, and sensors.

Today I write Molecules & Empires, a newsletter exploring how scientific breakthroughs reshape industries, economies, and power. I also publish The Biotech Edge on LinkedIn, reaching 24,000+ biotech professionals weekly.

I'm Ukrainian, currently living in Spain.